1.Introduction。Aging is a systemic and progressive challenge of significant societal,medical,and scientific urgency.With global populations aging rapidly,age-related diseases,such as neurodegeneration and cardiovascu...1.Introduction。Aging is a systemic and progressive challenge of significant societal,medical,and scientific urgency.With global populations aging rapidly,age-related diseases,such as neurodegeneration and cardiovascular dysfunction,are accelerating,underscoring the urgent need to understand the mechanisms of aging and develop effective interventions.The trending organ-on-a-chip(OoC)technology offers a powerful solution by recapitulating organ-or tissue-level functions.However,the applications of OoC in aging research remain limited,since most current systems are confined to models that simulate endpoint phenotypes rather than the dynamic evolution of aging itself.展开更多
基金supported by the National Institutes of Health(UH3TR003274,UH3TR003274-S1,UG3TR005836,R01HL166522,R01CA282451,and R21HL168656)the US National Science Foundation(CISE-CNS-2225698 and CISE-CNS-2525091)+1 种基金the Chan Zuckerberg Initiative(2024-347836)the Brigham Research Institute。
摘要1.Introduction。Aging is a systemic and progressive challenge of significant societal,medical,and scientific urgency.With global populations aging rapidly,age-related diseases,such as neurodegeneration and cardiovascular dysfunction,are accelerating,underscoring the urgent need to understand the mechanisms of aging and develop effective interventions.The trending organ-on-a-chip(OoC)technology offers a powerful solution by recapitulating organ-or tissue-level functions.However,the applications of OoC in aging research remain limited,since most current systems are confined to models that simulate endpoint phenotypes rather than the dynamic evolution of aging itself.